EMBJ
Earnings in 5 days · May 8, 2026 · Before open
Signal
Leaning Bearish1
Price
1
Move-0.14%Quiet session
Volume
1
Volume0.6× avgNormal activity
Technical
1
TrendFull DowntrendBelow 50D & 200D
PRICE
Prev Close
62.70
Open
62.56
Day Range61.51 – 63.31
61.51
63.31
52W Range43.80 – 80.75
43.80
80.75
51% of range
VOLUME & SIZE
Avg Volume
1.4M
Float
183.5M
FUNDAMENTALS
P/E Ratio
32.6x
EPS (TTM)
$1.92
Div Yield
No dividend
Performance
1D
-0.14%
5D
-0.30%
1M
-0.24%
3M
-15.20%
6M
-2.90%
YTD
-2.73%
1Y
+34.01%
Best: 1Y (+34.01%)Worst: 3M (-15.20%)
Quick Read
Earnings in 6d · May 8
Trend
DOWNTREND
Price below SMA50 & SMA200
Momentum
BEARISH
price below key MAs · thin 18% gross margin
Valuation
EXPENSIVE
P/E 33x vs ~20x sector
Health
STRONG
CR 1.5 · FCF $2.88/sh
Bearish
Key MetricsTTM
Market Cap$11.49B
Revenue TTM$7.60B
Net Income TTM$352.62M
Free Cash Flow$527.14M
Gross Margin17.5%
Net Margin4.6%
Operating Margin8.2%
Return on Equity10.4%
Return on Assets2.7%
Debt / Equity0.79
Current Ratio1.50
EPS TTM$1.93

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.

Health Radar
1 strong4 watch1 concern
43/100
Liquidity
1.50Watch
Leverage
0.79Strong
Coverage
2.4xWatch
ROE
10.4%Watch
ROIC
7.5%Concern
Cash
$1.9BWatch
ANALYST COVERAGE19 analysts
BUY
+3.8%upside to target
Buy
1579%
Hold
15%
Sell
316%
15 Buy (79%)1 Hold (5%)3 Sell (16%)
Full report →
Stock Health
Composite Score
4 of 7 signals bullish
5/10
Trend
Trend StateDowntrend (below both MAs)
Above SMA 50$64.19 (-2.5%)
Above SMA 200$63.07 (-0.7%)
Technicals
MA AlignmentGolden Cross (50D vs 200D +1.8%)
Fundamentals
Last EarningsBeat estimates
Analyst ConsensusBuy
LiquidityCurrent Ratio 1.50 — healthy liquidity
Upcoming Events
EEarnings ReportMay 4, 2026
Tomorrow
DEx-Dividend DateJul 31, 2026
In 89 days
Technicals
Market Position
Price Levels
52W High
$80.75+29.0%
SMA 50
$64.19+2.5%
SMA 200
$63.07+0.7%
Current
$62.61
52W Low
$43.80-30.0%
52-Week RangeMid-range
$43.8051th %ile$80.75
Earnings & Analysts

ANALYST ESTIMATES

Consensus of 8 analysts
Analyst revisions:EPS↓ Revised DownRevenue↓ Revised Down

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2025
$7.5B
$7.4B$7.5B
$2.26
±50%
High8
FY2026(current)
$8.5B
$8.4B$8.5B
+13.5%$2.86+26.3%
±2%
High8
FY2027
$9.6B
$9.4B$9.7B
+13.0%$3.66+27.9%
±15%
High8
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryEMBJ
Last 8Q
+106.7%avg beat
Beat 7 of 8 quartersMissed 1 Estimates rising
+129%
Q3'23
+56%
Q1'24
+42%
Q2'24
+100%
Q4'24
+100%
Q1'25
+90%
Q2'25
-51%
Q4'25
+388%
Q1'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
* Negative EPS shown at reduced height
Analyst Activity
All ratings →
No recent activity
UBSNeutral
Dec 5
UPGRADE
Wolfe ResearchOutperform
Jul 31
UPGRADE
HSBCHold → Buy
Jun 4
UPGRADE
Cowen & Co.Buy
Sep 4
UPGRADE
UBSBuy → Positive
Mar 26
DOWNGRADE
CFRABuy
Mar 19
UPGRADE
CitigroupNeutral → Mixed
Oct 16
UPGRADE
Financials
Dividends0.69% yield
+281.2% avg annual growth
Annual Yield0.69%
Semi-Annual Div.$0.2600
Est. Annual / Share$0.52
FrequencySemi-Annual
Q1'18
Q2'18
Q2'18
Q3'18
Q4'18
Q2'25
Q4'25
Q2'26

Dividend per payment — last 8 periods

News & Activity

EMBJ News

20 articles · 4h ago

About

No company information available